Alzheimer’s treatment hasn’t changed much in the past two decades, and the way researchers have been thinking about and approaching the disease may be to blame.
Guest: Damian Garde, reporter for Stat covering the biotech industry.
Host: Lizzie O’Leary
If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work.
Hosted on Acast. See acast.com/privacy for more information.
